387086006: Levodopa (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Receptor agonist\Dopamine receptor agonist\Dihydroxyphenylalanine\Levodopa (substance)

\Drug or medicament (substance)\Central nervous system agent (substance)\Antiparkinsonian agent (substance)\Dihydroxyphenylalanine\Levodopa (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Catecholamine and/or catecholamine derivative\Catecholamine\Dihydroxyphenylalanine\Levodopa (substance)

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Catecholamine and/or catecholamine derivative\Catecholamine\Dihydroxyphenylalanine\Levodopa (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Levodopa (substance)	Is a	Dopamine agent	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Levodopa (substance)	Is a	Dihydroxyphenylalanine	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Levodopa (substance)	Has disposition	Dopamine receptor agonist	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing levodopa (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Accidental levodopa poisoning	Causative agent (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Intentional levodopa poisoning	Causative agent (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
intoxication par le lévodopa d'intention indéterminée	Causative agent (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Levodopa adverse reaction	Causative agent (attribute)	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Levodopa allergy	Causative agent (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Levodopa overdose (disorder)	Causative agent (attribute)	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Accidental levodopa overdose	Causative agent (attribute)	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Intentional levodopa overdose	Causative agent (attribute)	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
surdose de lévodopa d'intention indéterminée	Causative agent (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Levodopa 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbidopa + levodopa 50mg/200mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbidopa + levodopa 25mg/100mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Poisoning caused by levodopa (disorder)	Causative agent (attribute)	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing carbidopa and levodopa (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Carbidopa+levodopa+entacapone	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Co-careldopa	Is a	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Co-careldopa 10mg/100mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Co-careldopa 25mg/100mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Co-careldopa 25mg/250mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Co-careldopa 50mg/200mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Co-careldopa 25mg/100mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Co-careldopa	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbidopa 10mg/levodopa 100mg orally disintegrating tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbidopa 25mg/levodopa 100mg orally disintegrating tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbidopa 25mg/levodopa 250mg orally disintegrating tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Levodopa with carbidopa	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Accidental levodopa poisoning	Causative agent (attribute)	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Intentional levodopa poisoning	Causative agent (attribute)	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Benserazide + levodopa adverse reaction	Causative agent (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Carbidopa + levodopa adverse reaction	Causative agent (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Allergy to benserazide and levodopa	Causative agent (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Allergy to carbidopa and levodopa	Causative agent (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Benserazide 12.5 mg and levodopa 50 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Benserazide 25 mg and levodopa 100 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Co-beneldopa 12.5mg/50mg dispersible tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Co-beneldopa 25mg/100mg m/r capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Co-beneldopa 25mg/100mg dispersible tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing benserazide and levodopa (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbidopa 18.75mg + levodopa 75mg + entacapone 200mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Levodopa allergy	Causative agent (attribute)	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing carbidopa and levodopa in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	Has basis of strength substance (attribute)	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Levodopa 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Levodopa 500 mg oral tablet	Has basis of strength substance (attribute)	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet	Has basis of strength substance (attribute)	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing carbidopa and levodopa in enteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Co-beneldopa 25mg/100mg prolonged-release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet	Has precise active ingredient	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each prolonged-release oral tablet	Has precise active ingredient	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each prolonged-release oral tablet	Has basis of strength substance (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet	Has precise active ingredient	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet	Has precise active ingredient	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Levodopa 500 mg oral tablet	Has precise active ingredient	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet	Has precise active ingredient	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet	Has precise active ingredient	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet	Has precise active ingredient	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	Has precise active ingredient	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Allergy to carbidopa and levodopa	Causative agent (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Allergy to benserazide and levodopa	Causative agent (attribute)	False	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing levodopa in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only carbidopa and entacapone and levodopa (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only carbidopa and levodopa (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only benserazide and levodopa (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only levodopa (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only carbidopa and levodopa in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Levodopa (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2

Page 1 of 2 End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461264012	Levodopa (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481200014	Levodopa	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1491864012	L-3-hydroxytyrosine	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
3766620018	L-dopa	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
1461264012	Levodopa (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1461264012	Levodopa (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481200014	Levodopa	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1481200014	Levodopa	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1491864012	L-3-hydroxytyrosine	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1491864012	L-3-hydroxytyrosine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1491864012	L-3-hydroxytyrosine	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
1491865013	L-dopa preparation	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1491865013	L-dopa preparation	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3635515011	L-dopa - Levodopa	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
3744688016	L-dopa - levodopa	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
3766620018	L-dopa	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
55081000195110	levodopa	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
69631000195114	Levodopa	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
820521000172119	lévodopa	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
820521000172119	lévodopa	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
55081000195110	levodopa	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
69631000195114	Levodopa	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module